Estonia - Kiestonia - Ravimiamet

sandoz pharmaceuticals d.d. - esomeprasool - süste-/infusioonilahuse pulber - 40mg 5tk; 40mg 1tk; 40mg 10tk; 40mg 20tk

Estonia - Kiestonia - Ravimiamet

grunenthal gmbh - esomeprasool - gastroresistentne tablett - 20mg 7tk; 20mg 140tk; 20mg 28tk; 20mg 14tk

Estonia - Kiestonia - Ravimiamet

grunenthal gmbh - esomeprasool - gastroresistentne tablett - 40mg 28tk; 40mg 14tk

Estonia - Kiestonia - Ravimiamet

lex ano uab - esomeprasool - gastroresistentne tablett - 20mg 28tk

Estonia - Kiestonia - Ravimiamet

lex ano uab - esomeprasool - gastroresistentne tablett - 40mg 28tk

Estonia - Kiestonia - Ravimiamet

lex ano uab - esomeprasool - gastroresistentne kõvakapsel - 40mg 14tk; 40mg 28tk

Estonia - Kiestonia - Ravimiamet

ideal trade links uab - esomeprasool - gastroresistentne tablett - 20mg 14tk; 20mg 7tk; 20mg 28tk

Estonia - Kiestonia - Ravimiamet

ideal trade links uab - esomeprasool - gastroresistentne tablett - 40mg 7tk; 40mg 28tk

Umoja wa Ulaya - Kiestonia - EMA (European Medicines Agency)

gilead sciences ireland uc - sofosbuvir, velpatasvir - c-hepatiit, krooniline - viirusevastased ravimid süsteemseks kasutamiseks - epclusa is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients 3 years of age and older (see sections 4. 2, 4. 4 ja 5.

Umoja wa Ulaya - Kiestonia - EMA (European Medicines Agency)

gilead sciences ireland uc - ledipasvir, sofosbuvir - c-hepatiit, krooniline - viirusevastased ravimid süsteemseks kasutamiseks - harvoni is indicated for the treatment of chronic hepatitis c (chc) in adult and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 ja 5. c-hepatiidi viiruse (hcv) genotüüp-eriaktiivsus vt lõigud 4. 4 ja 5.